Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 10761961)

1.

Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.

Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE.

Arch Intern Med. 2000 Apr 10;160(7):961-4.

PMID:
10761961
2.

Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.

Stühlinger MC, Stanger O.

Curr Drug Metab. 2005 Feb;6(1):3-14. Review.

PMID:
15720202
3.

[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].

Sydow K, Böger RH.

Z Kardiol. 2001 Jan;90(1):1-11. Review. German.

PMID:
11220081
4.

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S.

Ann Intern Med. 1999 Sep 7;131(5):363-75. Review.

PMID:
10475890
5.

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.

Stanger O, Weger M, Renner W, Konetschny R.

Clin Chem Lab Med. 2001 Aug;39(8):725-33. Review.

PMID:
11592442
6.

Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.

Moghadasian MH, McManus BM, Frohlich JJ.

Arch Intern Med. 1997 Nov 10;157(20):2299-308. Review. Erratum in: Arch Intern Med 1998 Mar 23;158(6):662.

PMID:
9361570
7.

Homocysteine as a novel risk factor for atherosclerosis.

Guthikonda S, Haynes WG.

Curr Opin Cardiol. 1999 Jul;14(4):283-91. Review.

PMID:
10448607
8.

Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?

Virdis A, Ghiadoni L, Versari D, Salvetti G, Pinto S, Favilla S, Taddei S, Salvetti A.

Curr Pharm Des. 2005;11(17):2187-97. Review.

PMID:
16026288
9.

Association between homocyst(e)ine levels and risk of vascular events.

Kaplan ED.

Drugs Today (Barc). 2003 Mar;39(3):175-92. Review.

PMID:
12730702
10.

[Hyperhomocyst(e)inemia--an independent risk factor of stroke].

Lalouschek W, Aull S, Deecke L, Schnider P, Uhl F, Zeiler K.

Fortschr Neurol Psychiatr. 1996 Jul;64(7):271-7. Review. German.

PMID:
8765893
11.

Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.

Kang SS, Wong PW.

Atherosclerosis. 1996 Jan 26;119(2):135-8. Review.

PMID:
8808490
12.

Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.

Parnetti L, Caso V, Amici S, Lanari A, Gallai V, Bottiglieri T.

Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):501-9. Review.

PMID:
12450225
13.

Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?

Virdis A, Ghiadoni L, Salvetti G, Versari D, Taddei S, Salvett A.

J Nephrol. 2002 Jul-Aug;15(4):414-21. Review.

PMID:
12243373
14.

Causes and consequences of hyperhomocyst(e)inemia.

Pietrzik K, Brönstrup A.

Int J Vitam Nutr Res. 1997;67(5):389-95. Review.

PMID:
9350483
15.

Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.

Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB.

Int J Epidemiol. 2002 Feb;31(1):59-70. Review.

16.

Hyperhomocyst(e)inemia and Thrombophilia.

Key NS, McGlennen RC.

Arch Pathol Lab Med. 2002 Nov;126(11):1367-75. Review.

PMID:
12421143
17.

Measurement of homocyst(e)ine in the prediction of arteriosclerosis.

Fortin LJ, Genest J Jr.

Clin Biochem. 1995 Apr;28(2):155-62. Review.

PMID:
7628074
18.
19.

Homocysteine and vascular dysfunction.

Lentz SR.

Life Sci. 1997;61(13):1205-15. Review.

PMID:
9324062
20.

The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.

Ubbink JB.

J Inherit Metab Dis. 1997 Jun;20(2):316-25. Review.

PMID:
9211204
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk